Abdallat Davis Farrage syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 12: | Line 12: | ||
eMedicineTopic = | | eMedicineTopic = | | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
| Line 32: | Line 32: | ||
* {{WhoNamedIt|synd|2058}} | * {{WhoNamedIt|synd|2058}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | |||
[[Category:Genetic disorders]] | |||
Latest revision as of 19:28, 8 August 2012
| Abdallat Davis Farrage syndrome | |
| OMIM | 270750 |
|---|---|
Overview
Abdallat Davis Farrage syndrome is a syndrome consisting of disordered skin and hair pigmentation, progressive spastic paraparesis and peripheral neuropathy. It is also known as neurocutaneous syndrome, Abdallat Type. The syndrome is most likely inherited autosomal recessive.
Symptoms
- Albinism (hair)
- Irregular decreased skin pigmentation
- Excessive freckling
- Insensitivity to pain
- Paraparesis/quadraparesis
References
- Abdallat A, Davis SM, Farrage J, McDonald WI (1980). "Disordered pigmentation, spastic paraparesis and peripheral neuropathy in three siblings: a new neurocutaneous syndrome". J Neurol Neurosurg Psychiatry. 43 (11): 962–6. PMID 7441281